BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3931004)

  • 1. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
    Fine A; Reynolds GP; Nakajima N; Jenner P; Marsden CD
    Neurosci Lett; 1985 Jul; 58(1):123-6. PubMed ID: 3931004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the cat.
    Ambrosio S; Blesa R; Mintenig GM; Palacios-Araus L; Mahy N; Gual A
    Toxicol Lett; 1988 Nov; 44(1-2):1-6. PubMed ID: 3263717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
    Di Paolo T; Bédard P; Daigle M; Boucher R
    Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P; Rupniak NM; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):85-90. PubMed ID: 6436758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E; Carlsson A
    Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
    Russ H; Mihatsch W; Gerlach M; Riederer P; Przuntek H
    Neurosci Lett; 1991 Feb; 123(1):115-8. PubMed ID: 1712088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of MPTP to the common marmoset does not alter cortical cholinergic function.
    Garvey J; Petersen M; Waters CM; Rose SP; Hunt S; Briggs R; Jenner P; Marsden CD
    Mov Disord; 1986; 1(2):129-34. PubMed ID: 3143064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
    Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD
    Eur J Pharmacol; 1990 May; 181(1-2):97-103. PubMed ID: 2117541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
    Allen JM; Cross AJ; Yeats JC; Ghatei MA; McGregor GP; Close SP; Pay S; Marriott AS; Tyers MB; Crow TJ
    Brain; 1986 Feb; 109 ( Pt 1)():143-57. PubMed ID: 2417654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
    Taquet H; Nomoto M; Rose S; Jenner P; Javoy-Agid F; Mauborgne A; Benoliel JJ; Marsden CD; Legrand JC; Agid Y
    Neuropeptides; 1988 Oct; 12(3):105-10. PubMed ID: 2468106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Brain Res; 1987 Jul; 415(2):293-9. PubMed ID: 3496938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M; Jenner P; Marsden CD
    Neurosci Lett; 1985 Jun; 57(1):37-41. PubMed ID: 3162113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Close SP; Marriott AS; Pay S
    Br J Pharmacol; 1985 Jun; 85(2):320-2. PubMed ID: 3928007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
    Corsini GU; Pintus S; Chiueh CC; Weiss JF; Kopin IJ
    Eur J Pharmacol; 1985 Dec; 119(1-2):127-8. PubMed ID: 3002815
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
    Ghilardi MF; Chung E; Bodis-Wollner I; Dvorzniak M; Glover A; Onofrj M
    Life Sci; 1988; 43(3):255-62. PubMed ID: 3260986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S; Ambrosio S; Garofalo P; Gerli P
    Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.